Examining the Association of Rare Allelic Variants in Urate Transporters SLC22A11, SLC22A13, and SLC17A1 with Hyperuricemia and Gout

Jiří Vávra,Kateřina Pavelcová,Jana Mašínová,Lenka Hasíková,Eliška Bubeníková,Aneta Urbanová,Andrea Mančíková,Blanka Stibůrková

DOI: https://doi.org/10.1155/2024/5930566

2024-01-06

Disease Markers

Abstract:Genetic variations in urate transporters play a significant role in determining human urate levels and have been implicated in developing hyperuricemia or gout. Polymorphism in the key urate transporters, such as ABCG2, URAT1, or GLUT9 was well-documented in the literature. Therefore in this study, our objective was to determine the frequency and effect of rare nonsynonymous allelic variants of SLC22A11, SLC22A13, and SLC17A1 on urate transport. In a cohort of 150 Czech patients with primary hyperuricemia and gout, we examined all coding regions and exon–intron boundaries of SLC22A11, SLC22A13, and SLC17A1 using PCR amplification and Sanger sequencing. For comparison, we used a control group consisting of 115 normouricemic subjects. To examine the effects of the rare allelic nonsynonymous variants on the expression, intracellular processing, and urate transporter protein function, we performed a functional characterization using the HEK293A cell line, immunoblotting, fluorescent microscopy, and site directed mutagenesis for preparing variants in vitro. Variants p.V202M (rs201209258), p.R343L (rs75933978), and p.P519L (rs144573306) were identified in the SLC22A11 gene (OAT4 transporter); variants p.R16H (rs72542450), and p.R102H (rs113229654) in the SLC22A13 gene (OAT10 transporter); and the p.W75C variant in the SLC17A1 gene (NPT1 transporter). All variants minimally affected protein levels and cytoplasmic/plasma membrane localization. The functional in vitro assay revealed that contrary to the native proteins, variants p.P519L in OAT4 ( p ≤ 0.05 ), p.R16H in OAT10 ( p ≤ 0.05 ), and p.W75C in the NPT1 transporter ( p ≤ 0.01 ) significantly limited urate transport activity. Our findings contribute to a better understanding of (1) the risk of urate transporter-related hyperuricemia/gout and (2) uric acid handling in the kidneys.

genetics & heredity,pathology,medicine, research & experimental,biotechnology & applied microbiology

What problem does this paper attempt to address?

The paper aims to study the frequency of rare missense allele variants in urate transporters SLC22A11, SLC22A13, and SLC17A1 and their impact on urate transport. Specifically, the study analyzed all coding regions and exon-intron boundaries of these genes in a cohort of 150 Czech patients with hyperuricemia and gout using PCR amplification and Sanger sequencing. For comparison, a control group of 115 individuals with normal uric acid levels was also used.

The study identified several rare variants and assessed their impact on protein expression, intracellular processing, and urate transporter function through functional characterization experiments, including HEK293A cell lines, immunoblotting, fluorescence microscopy, and site-directed mutagenesis. Among these, p.P519L (OAT4), p.R16H (OAT10), and p.W75C (NPT1) significantly restricted urate transport activity.

These findings contribute to a better understanding of:
1. The risk of hyperuricemia/gout related to urate transporters;
2. The mechanisms of renal handling of urate.